• Profile
Close

3rd COVID vaccine dose strongly boosts protection against Delta variant: Pfizer

IANS Jul 29, 2021

American biopharmaceutical company Pfizer has said the third dose of its COVID-19 vaccine can "strongly" boost protection against the Delta variant.

For our comprehensive coverage and latest updates on COVID-19 click here.


Antibody levels against the Delta variant in people aged 18 to 55 who receive a third dose of the Pfizer/BioNTech vaccine are greater than five-fold than following a second dose, according to data posted at the company's teleconference, Xinhua reported. Among people aged 65 to 85, the Pfizer data suggest that antibody levels against the Delta variant after receiving the third dose are greater than 11-fold than following a second dose. Pfizer anticipates applying for emergency use authorisation for a third dose of its vaccine as soon as next month, Mikael Dolsten, who leads worldwide research, development and medical for Pfizer, was quoted by CNN as saying at the teleconference.

Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay